OTCQX:MRVFF - Post by User
Comment by
daydream1on Apr 07, 2009 9:02am
![](https://assets.stockhouse.com/kentico-cms/0338-00/images/Sprite.svg#id_Post_Views_Icon)
393 Views
Post# 15901464
RE: Depth.......
RE: Depth.......Largest Short Position Decreases 2009.03.13 - 2009.03.31
NRI 1,948,300 10,104,800 -8,156,500
Looks like the short have mostly cover.
As I see it, even with FDA approval, but with out a solid US partner, I can see the stock price increase that must. Why NRI has not yet found a US partner? If at this point in the evolution of Pennsaid NRI is unable to secure a deal with a partner, what does that say about the US pharma industry interest in this product? Or is it that management is trying, or I should said is hoping, to set a beating war in between potential partners. If that is the case it is by all means bad management.
Or management is looking at a buyout. That would explain management insisting effort to have the re-issue offer of early warrants buy back in order to clear their book for a buyout??
Goodluck
D.